TY  - JOUR

T1  - EE359 Cost-Effectiveness of Pembrolizumab + Chemotherapy Versus Cetuximab-Containing Regimens ‘Extreme’ and ‘TPEx’, for R/M SCCHN Patients with a CPS between 1 and 19, in Italy

JO  - Value in Health

UR  - http://dx.doi.org/10.1016/j.jval.2023.09.625

PY  - 2023/12/01

AU  - Ivanyi P

AU  - Bullement A

AU  - Ciccarone A

AU  - Schlichting M

AU  - Naik J

AU  - Colombo GL

AU  - Gandola A

AU  - Pescott CP

ED  - 

DO  - DOI: 10.1016/j.jval.2023.09.625

PB  - Elsevier BV

VL  - 26

IS  - 12

SP  - S120

EP  - S120

Y2  - 2024/12/22

ER  -